Paper42012295
Construction and characterization of novel Mycobacterium tuberculosis-derived triple and quadruple knockout vaccines against tuberculosis.
Garnica O and 13 others. Infect Immun, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Construction and characterization of novel Mycobacterium tuberculosis-derived triple and quadruple knockout vaccines against tuberculosis. Papers, record 42012295. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42012295
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Construction and characterization of novel Mycobacterium tuberculosis-derived triple and quadruple knockout vaccines against tuberculosis.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Mycobacterium tuberculosis | Major topic |
| Tuberculosis Vaccines | Major topic |
| Tuberculosis | Major topic |
| Animals | |
| Mice | |
| Female | |
| Gene Knockout Techniques | |
| Vaccines, Attenuated | |
| Bacterial Proteins | |
| Disease Models, Animal | |
| Gene Deletion |
Source PubMed
Grants11
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| 1R15AI156647; 1RO1AI175837 | National Institute of Allergy and Infectious Diseases | R15AI156647 | PubMed | NIH RePORTER | |
| R01 AI184394 | NIAID NIH HHS | United States | R01AI184394 | PubMed | NIH RePORTER |
| R16GM149497 | NIGMS NIH HHS | United States | R16GM149497 | PubMed | NIH RePORTER |
| R01AI161015, R01AI184551, R01AI184394, R01AI187440 | National Institute of Allergy and Infectious Diseases | R01AI161015 | PubMed | NIH RePORTER | |
| R01 AI187440 | NIAID NIH HHS | United States | R01AI187440 | PubMed | NIH RePORTER |
| R01 AI175837 | NIAID NIH HHS | United States | R01AI175837 | PubMed | NIH RePORTER |
| R15 AI156647 | NIAID NIH HHS | United States | R15AI156647 | PubMed | NIH RePORTER |
| R01 AI184551 | NIAID NIH HHS | United States | R01AI184551 | PubMed | NIH RePORTER |
| R01 AI161015 | NIAID NIH HHS | United States | R01AI161015 | PubMed | NIH RePORTER |
| RSG-22-170-01-RMC | American Cancer Society | PubMed | PubMed | ||
| R16 GM149497 | NIGMS NIH HHS | United States | R16GM149497 | PubMed | NIH RePORTER |
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31064713 | Enhanced delivery of Mycobacterium tuberculosis antigens to antigen presenting cells using RVG peptide. | Tuberculosis (Edinb) | 2019 | https://conductscience.org/library/papers/31064713 | PubMed |
| 2 | 27079235 | Mycobacterium tuberculosis EIS gene inhibits macrophage autophagy through up-regulation of IL-10 by increasing the acetylation of histone H3. | Biochem Biophys Res Commun | 2016 | https://conductscience.org/library/papers/27079235 | PubMed |
| 3 | 28942172 | Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: Biology, immune-pathogenicity, applications in diagnosis, and vaccine design. | Microb Pathog | 2017 | https://conductscience.org/library/papers/28942172 | PubMed |
| 4 | 17671656 | Enhanced priming of adaptive immunity by a proapoptotic mutant of Mycobacterium tuberculosis. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17671656 | PubMed |
| 5 | 38022657 | Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates. | Front Immunol | 2023 | https://conductscience.org/library/papers/38022657 | PubMed |
| 6 | 37828070 | Key advances in vaccine development for tuberculosis-success and challenges. | NPJ Vaccines | 2023 | https://conductscience.org/library/papers/37828070 | PubMed |
| 7 | 37654500 | Advances in protein subunit vaccines against tuberculosis. | Front Immunol | 2023 | https://conductscience.org/library/papers/37654500 | PubMed |
| 8 | 24349004 | ESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination. | PLoS One | 2013 | https://conductscience.org/library/papers/24349004 | PubMed |
| 9 | 12368434 | Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. | Microbiology (Reading) | 2002 | https://conductscience.org/library/papers/12368434 | PubMed |
| 10 | 22574140 | The fbpA/sapM double knock out strain of Mycobacterium tuberculosis is highly attenuated and immunogenic in macrophages. | PLoS One | 2012 | https://conductscience.org/library/papers/22574140 | PubMed |
| 11 | 27222470 | Deletion of nuoG from the Vaccine Candidate Mycobacterium bovis BCG ΔureC::hly Improves Protection against Tuberculosis. | mBio | 2016 | https://conductscience.org/library/papers/27222470 | PubMed |
| 12 | 9148954 | Arrest of mycobacterial phagosome maturation is caused by a block in vesicle fusion between stages controlled by rab5 and rab7. | J Biol Chem | 1997 | https://conductscience.org/library/papers/9148954 | PubMed |
| 13 | 24890836 | Novel vaccination strategies against tuberculosis. | Cold Spring Harb Perspect Med | 2014 | https://conductscience.org/library/papers/24890836 | PubMed |
| 14 | 21471301 | Relief from Zmp1-mediated arrest of phagosome maturation is associated with facilitated presentation and enhanced immunogenicity of mycobacterial antigens. | Clin Vaccine Immunol | 2011 | https://conductscience.org/library/papers/21471301 | PubMed |
| 15 | 25657094 | Deletion of zmp1 improves Mycobacterium bovis BCG-mediated protection in a guinea pig model of tuberculosis. | Vaccine | 2015 | https://conductscience.org/library/papers/25657094 | PubMed |
| 16 | 25869896 | Increased protective efficacy of recombinant BCG strains expressing virulence-neutral proteins of the ESX-1 secretion system. | Vaccine | 2015 | https://conductscience.org/library/papers/25869896 | PubMed |
| 17 | 36475477 | [Genetic Engineering in Mycobacteria]. | Mol Biol (Mosk) | 2022 | https://conductscience.org/library/papers/36475477 | PubMed |
| 18 | 15958066 | Immunogenicity and protective efficacy of the Mycobacterium tuberculosis fadD26 mutant. | Clin Exp Immunol | 2005 | https://conductscience.org/library/papers/15958066 | PubMed |
| 19 | 18946503 | PhoP: a missing piece in the intricate puzzle of Mycobacterium tuberculosis virulence. | PLoS One | 2008 | https://conductscience.org/library/papers/18946503 | PubMed |
| 20 | 28297677 | Recombinant BCG Expressing ESX-1 of Mycobacterium marinum Combines Low Virulence with Cytosolic Immune Signaling and Improved TB Protection. | Cell Rep | 2017 | https://conductscience.org/library/papers/28297677 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42792714 | Role of Exosomes During Mycobacterium Tuberculosis Infection: A Double-Edged Sword. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792714 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42012295
GET https://conductscience.org/api/papers/v1/42012295/references?page=2